Maternal
|
|
Transfusion medicine
†
|
|
ABO group |
B |
RhD phenotype |
Serologic weak D phenotype: 2 + reaction strength‡
|
RhCE phenotype |
C–E–c+e+ |
Antibody screen |
Anti-U |
DAT |
Negative |
Red cell genotyping†
|
|
RHD allele |
RHD*weak D type 4.0
|
RHD zygosity |
Hemizygous |
Hematology
† |
|
Hemoglobin, g/dL |
|
Antepartum |
9.8 (10.0–15.0) |
Postpartum |
8.9 (10.0–15.0) |
Neonatal
|
|
Transfusion medicine
§
|
|
ABO group |
B |
RhD phenotype |
D+ |
RhCE phenotype |
C–E–c+e+ |
DAT |
Negative |
Red cell genotyping§
|
|
RHD allele |
RHD*weak D type 4.0 and normal RHD
|
RHD zygosity |
Compound heterozygous |
Hematology
|
|
Hemoglobin, g/dL |
17.6 (14.0–24.0) |
Unconjugated bilirubin, mg/dL |
|
At birth |
4.9 (<6) |
4 hours after birth |
5.5 (<6) |
Reticulocyte count, % |
4.46 (3.0–7.0) |